Interestingly, studies have found that the absence of IL-17 expression can decrease RANKL expression, yet this has minimal effect on proteoglycan-induced arthritis, with bone resorption levels in IL-17-deficient mice comparable to those in wild-type mice. This evidence concerns the gene IL17A and arthritic joint disease.